We recently reported that elevated expression of a UPR gene signature consisting of UPR sensors and downstream targets of UPR activation is tightly correlated with therapy resistance, tumor recurrence and a poor prognosis in ERα+ breast cancer [32]. Here, ESR1 is linked to neoplasm.